Doctorglasses Chain Income Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Operating Revenue	1,407	1,339	1,190	1,161	951.51	881.1
Other Revenue	14	21.14	12.68	14.63	10.72	6.37
Revenue	1,421	1,360	1,203	1,176	962.24	887.47
Revenue Growth	10.30%	13.10%	2.29%	22.20%	8.43%	35.22%
Cost of Revenue	557.89	546.52	470.37	442.18	373.9	313.84
Gross Profit	862.98	813.87	732.44	733.69	588.34	573.63
Selling, General & Admin	654.28	630	592.02	564.92	498.69	454.23
Research & Development	1.91	2.01	3.08	4.67	-	-
Other Operating Expenses	6.65	5.86	4.15	4.99	1.91	2.64
Operating Expenses	662.66	638.2	599.58	575.31	501.06	457.35
Operating Income	200.32	175.66	132.86	158.38	87.28	116.28
Interest Expense	-3.25	-7.46	-8.61	-7.69	-9.02	-9.09
Interest & Investment Income	8.12	13.04	16.3	15.24	9.43	9.4
Currency Exchange Gain (Loss)	-1.19	-1.19	-0.77	0.52	0.31	0.33
Other Non Operating Income (Expenses)	-11.42	-4.52	-4.61	-3.77	-3.44	-3.5
EBT Excluding Unusual Items	192.58	175.53	135.16	162.68	84.57	113.42
Impairment of Goodwill	-	-	-12.14	-5.3	-	-
Gain (Loss) on Sale of Investments	45.54	24.39	2.21	4.58	-0.83	-0.39
Gain (Loss) on Sale of Assets	1.38	0.52	2.35	0.88	2.26	0.59
Asset Writedown	-13.91	-9.51	-4.04	-0.14	-0.1	-0.1
Other Unusual Items	2.23	1.06	5.57	1.44	6.94	7.71
Pretax Income	227.83	191.99	129.12	164.13	92.84	121.24
Income Tax Expense	46.15	38.3	27.8	32.37	18.4	26.74
Earnings From Continuing Operations	181.67	153.69	101.32	131.76	74.44	94.5
Minority Interest in Earnings	-6.06	-5.08	2.31	-3.69	1.37	0.28
Net Income	175.61	148.61	103.63	128.06	75.81	94.78
Net Income to Common	175.61	148.61	103.63	128.06	75.81	94.78
Net Income Growth	63.70%	43.40%	-19.08%	68.93%	-20.02%	37.02%
Shares Outstanding (Basic)	322	320	315	315	307	308
Shares Outstanding (Diluted)	322	320	315	315	314	314
Shares Change	2.94%	1.49%	0.13%	0.46%	-0.04%	2.15%
EPS (Basic)	0.54	0.46	0.33	0.41	0.25	0.31
EPS (Diluted)	0.54	0.46	0.33	0.41	0.24	0.30
EPS Growth	59.03%	41.30%	-19.18%	68.16%	-19.99%	34.13%

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Free Cash Flow	344.6	276.29	249.53	259.34	182.13	170.83
Free Cash Flow Per Share	1.07	0.86	0.79	0.82	0.58	0.55
Dividend Per Share	1.929	1.929	0.148	0.330	0.165	0.275
Dividend Growth	3087.77%	1199.60%	-54.99%	100.06%	-40.01%	42.85%
Gross Margin	60.74%	59.83%	60.89%	62.40%	61.14%	64.64%
Operating Margin	14.10%	12.91%	11.05%	13.47%	9.07%	13.10%
Profit Margin	12.36%	10.92%	8.62%	10.89%	7.88%	10.68%
Free Cash Flow Margin	24.25%	20.31%	20.75%	22.05%	18.93%	19.25%
EBITDA	208.82	182.07	147.62	172.3	97.85	125.52
EBITDA Margin	14.70%	13.38%	12.27%	14.65%	10.17%	14.14%
D&A For EBITDA	8.5	6.4	14.76	13.92	10.57	9.23
EBIT	200.32	175.66	132.86	158.38	87.28	116.28
EBIT Margin	14.10%	12.91%	11.05%	13.47%	9.07%	13.10%
Effective Tax Rate	20.26%	19.95%	21.53%	19.72%	19.82%	22.05%
Revenue as Reported	674.01	1,360	1,203	1,176	962.24	887.47
Advertising Expenses	-	9.28	7.69	6.98	4.23	2.72